The Drug Science Podcast | 51. Music and Psychedelics with Mendel Kaelen

Have you ever felt moved by a song? Have had music affect your mood? For many of us music has a therapeutic quality to it. So what about combining that with psychedelics?

Show Notes

In this week’s episode we'll meet Dr Mendel Kaelen, CEO of Wavepaths, a London-based company researching and developing methods for music-assisted psychotherapy.

Prior to Wavepaths, Dr Kaelen worked as a PhD student and post-doctoral neuroscientist at Imperial College London with a special focus of the role of music in psychedelic therapy. Combining his passion to both music and neuroscience he advocates for the therapeutic use of music in talks and publications that has been featured in Nature News, San Francisco Chronicles, Vice Motherboard, Rolling Stone, TEDx and others.

Tune in to this week’s episode to gain some insight on how music actually affects our brains and hence ourselves.

Ketamine

Psychedelics

Out of body experience

Brocas area (inferior frontal gyrus)

Hyper-connectivity in the brain under specific drugs

Precuneus

Serotonin 2a receptor

★ Support this podcast ★

What is The Drug Science Podcast?

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.